According to a statement released by the Food and Drugs Administration (FDA) in a Federal Register notice, manufacturers of nicotine gum and other nicotine replacement products can now use new labels that will permit smokers to opt for more than one therapy at one time. In accordance with the new FDA labelling regulations, people looking forward to quit smoking can now use GlaxoSmithKline Plc (GSK)’s Nicorette gum and similar other products in combination with other treatments and for longer periods.
Margaret Hamburg, the Commissioner of FDA, states that the FDA hopes that the newly initiated changes on product labels will allow people to use them successfully for quit smoking. She also adds that this will reduce the rate of tobacco dependence in the country.
The label changes were demanded by the public health and consumer groups, with the assertion that the current product labels were inadequate and might have disheartened people from purchasing quit smoking products.
Source: bloomberg.com, Date: 1st April 2013